Not applicableUnknownNCT05188430What this trial is testingMetabolic Effect of an Innovative Chitosan FormulationWho this might be right forHypercholesterolemiaOverweight and Obesity University of Bologna 60
Post-approval studies (Phase 4)Study completedNCT00645151What this trial is testingThe Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High CholesterolWho this might be right forDyslipidemias Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512
Early research (Phase 1)Study completedNCT01959971What this trial is testingEffect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-CholesterolWho this might be right forHypercholesterolemia Sanofi 20
Testing effectiveness (Phase 2)Study completedNCT02591836What this trial is testingEfficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With AtorvastatinWho this might be right forHypercholesterolemia NeuroBo Pharmaceuticals Inc. 277
Not applicableLooking for participantsNCT04370899What this trial is testingEarly Detection of Familial Hypercholesterolemia in ChildrenWho this might be right forFamilial HypercholesterolemiaFamilial Hypercholesterolemia - HeterozygousFamilial Hypercholesterolemia - Homozygous Institut Investigacio Sanitaria Pere Virgili 400
Large-scale testing (Phase 3)Study completedNCT05763875What this trial is testingEfficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.Who this might be right forHypercholesterolemia Novartis Pharmaceuticals 350
Not applicableStudy completedNCT03516955What this trial is testingEfficacy and Safety of a Generic Rosuvastatin in a Real-world SettingWho this might be right forPrimary Hypercholesterolemia Hikma Pharmaceuticals LLC 317
Not applicableStudy completedNCT05267522What this trial is testingIndependent Effects of High-cholesterol (High-egg) and High-saturated Fat Diets on LDL-cholesterolWho this might be right forHypercholesterolemiaHyperlipidemiasPhysical Inactivity+1 more University of South Australia 77
Large-scale testing (Phase 3)Study completedNCT05004675What this trial is testingTrial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD PatientsWho this might be right forHypercholesterolemiaAtherosclerotic Ischemic Disease LIB Therapeutics LLC 166
Post-approval studies (Phase 4)Not Yet RecruitingNCT07508254What this trial is testingTriple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary SyndromeWho this might be right forAcute Coronary Syndromes (ACS)Hypercholesterolemia Punjab Institute of Cardology 120
Post-approval studies (Phase 4)Ended earlyNCT00427960What this trial is testingStudy of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mgWho this might be right forHypercholesterolaemia AstraZeneca 55
Large-scale testing (Phase 3)Study completedNCT06005597What this trial is testingStudy of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying TherapiesWho this might be right forDyslipidemiasHypercholesterolemiaFamilial Hypercholesterolemia+2 more NewAmsterdam Pharma 407
Large-scale testing (Phase 3)Study completedNCT01516879What this trial is testingDurable Effect of PCSK9 Antibody CompARed wiTh placEbo StudyWho this might be right forHypercholesterolemia Amgen 905
Post-approval studies (Phase 4)Study completedNCT00166530What this trial is testingEASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)Who this might be right forAtherosclerosis Organon and Co 367
Not applicableStudy completedNCT07409636What this trial is testingAssess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult PatientsWho this might be right forHypercholesterolemiaMixed Dyslipidemia Novartis Pharmaceuticals 11,991
Large-scale testing (Phase 3)Study completedNCT04790513What this trial is testingTrial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD PatientsWho this might be right forHypercholesterolemiaCardiovascular Diseases LIB Therapeutics LLC 204
Testing effectiveness (Phase 2)Study completedNCT01652703What this trial is testingEvaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese SubjectsWho this might be right forHypercholesterolemia and High Risk for Cardiovascular Events Amgen 310
Large-scale testing (Phase 3)Study completedNCT01763827What this trial is testingMonoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2Who this might be right forHyperlipidemia Amgen 615
Early research (Phase 1)Enrolling By InvitationNCT06504043What this trial is testingA Study on Evaluating the Safety of HST101 in Healthy Chinese ParticipantsWho this might be right forHypercholesterolemiaHealthy VolunteersLDL-Cholesterol Hasten Biopharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT01941836What this trial is testingEvaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic PatientsWho this might be right forHypercholesterolemia Esperion Therapeutics, Inc. 349